Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000219383 | SCV000269580 | benign | not specified | 2015-11-11 | criteria provided, single submitter | clinical testing | Ile2074Val in exon 51 of OTOGL: This variant is not expected to have clinical si gnificance because it has been identified in 7.6% (641/8456) of European America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs2034528). |
Gene |
RCV000219383 | SCV000717024 | benign | not specified | 2017-05-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV002054404 | SCV002341438 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV002054404 | SCV005231931 | benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV000219383 | SCV001742083 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000219383 | SCV001959631 | benign | not specified | no assertion criteria provided | clinical testing |